International Collaboration
How We Started
A Message from the Managing Director
Vision & Mision
International Collaboration
Manufacturing & Marketing
International Collaboration
” In new markets, we aim to develop a strong formulation and manufacturing capabilities to establish ourselves as early generic players in the market. “
” In new markets, we aim to develop a strong formulation and manufacturing capabilities to establish ourselves as early generic players in the market. “
In addition, we will increase our business development capabilities to identify new niche market segments. Fahrenheit plans to expand its influence internationally with other pharmaceutical industries, particularly on hospital and niche products. We will create strong bonds with our partners overseas in a way that is beneficial to our partners and to ourselves. Below are some examples as a result of our collaboration
PHOSPHATE BINDER NON CALCIUM
FOSRENOL (LANTHANUM CARBONATE), LAUNCH SINCE 2009
GENERAL INHALATION ANESTHETIC
TERRELL (ISOFLURANE)
LAUNCH SINCE 2006
SOJOURN (SEVOFLURANE)
LAUNCH SINCE 2007
HEPATITIS C
HEPCINAT (SOFOSBUVIR)
LAUNCH 2019
NATDAC (DACLATASVIR)
LAUNCH 2019
ORAL HIGH POTENCY PRODUCT ONCOLOGY
NATERAN (EXEMESTANE)
LAUNCH 2019
GREEN VIII (Factor VIII)
LAUNCH 2023
GC FLU vaccine